Biomea Fusion Announces FDA Clearance of Investigational New … – BioSpace
Skip to main content Published: Dec 14, 2022 REDWOOD CITY, Calif., Dec. 14, 2022 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering…